Upload Avatar (500 x 500)
Tao Zhu
Basic Medical Sciences
University of Science and Technology of China
Anhui
Language: English, Chinese
Tumor
Precision Medicine
Molecular Diagnosis
Treatment
Nanomaterials
Biological Effects
Cancer
Research
Pathology
Translational Medicine
Areas of Focus
- Tumor Precision Medicine Related Molecular Diagnosis and Treatment
- Biological Effects of Nanomaterials
Work Experience
- Current - University of Science and Technology of China - Professor
- Current - National Research Center for Microscale Material Science - PI
- Current - Anhui Provincial Hospital - Joint Professor
Academic Background & Achievements
- Bachelor's Degree in Medicine: Wuhan University
- PhD in Science: National University of Singapore
- Postdoctoral Research: Johns Hopkins University
- Published over 110 SCI papers, with over 6000 citations and an h-index of 46
Publications
- Cancer Stem Cell Regulated Phenotypic Plasticity Protects Metastasizing Tumor Cells from Ferroptosis, Wu M, Zhang X, Chiou YS, Qian W, Liu X, Zhang M, Yan H, Li S, Li T, Han X, Qian P, Liu S, Pan Y, Wu Z, Lobie PE, Zhu T, 2021
- Analysis of the oestrogen receptor-associated lncRNA landscape identifies a role for ERLC1 in breast cancer therapy, Yuan H, Yan L, Wu M, Shang Y, Guo Q, Zhang X, Zhu Y, Wu Z, Lobie PE, Zhu T, 2021
- Long-term pulmonary pre-exposure to multi-walled carbon nanotubes promotes breast cancer metastatic cascades, Lu X, Zhu Y, Bai R, Wu Z, Qian W, Yang L, Pandey V, Liu Y, Lobie PE, Chen C, Zhu T, 2019
- Loss of Estrogen Regulated MIR135A1 at 3p21.1 Promotes Tamoxifen Resistance in Breast Cancer Cells, Zhang W, Wu M, Kang Y, Chong QY, Zhang M, Qian W, Zhang X, Hu L, Zhong Y, Qian P, Kong X, Li G, Ding K, Lobie PE, Zhu T, 2018
- CCAR1 5'UTR as a natural miRancer of miR-1254 overrides tamoxifen resistance, Li G, Wu X, Qian W, Wu ZS, Cai H, Sun X, Zhang W, Tan S, Qian P, Ding K, Lu X, Zhang X, Yan H, Song H, Huang S, Wu Q, Lobie PE, Shan G, Zhu T, 2016
- Gd-metallofullerenol nanomaterial as non-toxic breast cancer stem cell specific inhibitor, Liu Y, Chen C, Qian P, Lu X, Sun B, Zhang X, Wang L, Gao X, Li H, Chen Z, Tang J, Zhang W, Dong J, Bai R, Lobie PE, Wu Q, Liu S, Zhang H, Zhao F, Wicha MS, Zhu T, Zhao Y, 2015
- Nanotoxicity: A growing need for study in the endocrine system, Lu X, Liu Y, Kong X, Lobie PE, Chen C, Zhu T, 2013
- HOXB7 renders breast cancer resistant to tamoxifen through activation of the EGFR Pathway, Jin K, Kong X, Shah T, Penet MF, Wildes F, Sgroi DC, Ma XJ, Huang Y, Kallioniemi A, Landberg G, Bieche I, Lobie PE, Davidson NE, Zaver M, Bhujwalla ZM, Zhu T, Sukumar S, 2012
- Loss of SNAIL regulated miR-128-2 on chromosome 3p22.3 promotes mammary epithelial cell oncogenic transformation via targeting multiple stem cell factors, Qian PX, Banerjee A, Wu ZS, Zhang X, Wang H, Pandey V, Zhang WJ, Lu XF, Tan S, Lobie PE, Zhu T, 2012
- Pivotal Role of Reduced let-7g Expression in Breast Cancer Invasion and Metastasis, Qian P, Zuo Z, Wu Z, Meng X, Li G, Wu Z, Zhang W, Tan S, Pandey V, Yao Y, Wang P, Zhao L, Wang J, Wu Q, Song E, Lobie PE, Yin Z, Zhu T, 2011
Awards
- Awarded by the Endocrine Society of America
- Awarded by the Susan G. Komen Cancer Foundation
- Supported by the French Innovation Talent Program
- Supported by the Wuhan High-tech Zone '3551' Talent Program
